Tag: hepatocellular carcinoma
FDA-Approved Drug Restores Immunotherapy Efficacy in Rare Liver Cancer by Releasing Trapped T Cells
Researchers have identified that rare liver cancers evade immunotherapy by trapping immune T cells in fibrous tissue. An FDA-approved drug…
Submit Your Paper to GMJ
No APC until January 2027.